P. Savvides
Papers
2
Total Citations
69
H-Index
2
About
P. Savvides is a leading clinical researcher in head and neck oncology, with a focused expertise in human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma. Their major contributions center on pioneering de-escalation treatment strategies aimed at reducing the toxicity of standard therapies while maintaining excellent oncologic outcomes. Savvides was instrumental in the Phase III MC1675 trial, which evaluated De-Escalated Adjuvant Radiation Therapy (DART) against standard adjuvant treatment, a landmark study garnering 53 citations. This work, alongside the prospective MC1273 trial, has reshaped clinical paradigms by demonstrating that carefully selected patients can safely receive less intensive radiation, thereby minimizing long-term side effects. Further impact is shown through a 2023 analysis of 30-day morbidity and mortality after transoral robotic surgery within these de-escalation protocols (16 citations), providing critical safety data for surgical approaches. Savvides’ research bridges the gap between aggressive treatment and quality of life, offering a compelling model for personalized, risk-adapted care in HPV-positive disease. Their work is essential reading for students and clinicians exploring the future of de-intensified therapy in head and neck cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2